BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17666481)

  • 1. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
    Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
    Gielen M; Mesotten D; Brugts M; Coopmans W; Van Herck E; Vanhorebeek I; Baxter R; Lamberts S; Janssen JA; Van den Berghe G
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2558-66. PubMed ID: 21632816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of intensive insulin therapy on the mortality of critically ill patients in intensive care unit: a meta-analysis].
    Li J; Li L; Ma B; Yang KH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):349-52. PubMed ID: 19570341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU?
    Okabayashi T; Shima Y
    Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):190-9. PubMed ID: 24378668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy insight: the effect of tight glycemic control in acute illness.
    Langouche L; Vanhorebeek I; Van den Berghe G
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):270-8. PubMed ID: 17315035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
    Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
    Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
    Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
    Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol response to critical illness: effect of intensive insulin therapy.
    Vanhorebeek I; Peeters RP; Vander Perre S; Jans I; Wouters PJ; Skogstrand K; Hansen TK; Bouillon R; Van den Berghe G
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3803-13. PubMed ID: 16868064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing glycemic variability in critically ill patients: A prospective cohort study comparing insulin infusion therapy with insulin sliding scale.
    Almagthali A; Alsohimi S; Alkhalaf A; Al Sulaiman K; Aljuhani O
    Sci Rep; 2024 May; 14(1):10128. PubMed ID: 38698018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of intensive insulin therapy in critically ill patients.
    Whyte MB; Jackson NC; Shojaee-Moradie F; Treacher DF; Beale RJ; Jones RH; Umpleby AM
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E697-705. PubMed ID: 20028969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose dysregulation and neurological injury biomarkers in critically ill children.
    Vanhorebeek I; Gielen M; Boussemaere M; Wouters PJ; Grandas FG; Mesotten D; Van den Berghe G
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4669-79. PubMed ID: 20668035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive insulin therapy in practice: can we do it?
    Dossett LA; Collier B; Donahue R; Mowery NT; Dortch MJ; Guillamondegui O; Diaz JJ; May AK
    JPEN J Parenter Enteral Nutr; 2009; 33(1):14-20. PubMed ID: 18832598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive versus conventional insulin therapy in critically ill neurologic patients.
    Green DM; O'Phelan KH; Bassin SL; Chang CW; Stern TS; Asai SM
    Neurocrit Care; 2010 Dec; 13(3):299-306. PubMed ID: 20697836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tight glucose control in critically ill children--a systematic review and meta-analysis.
    Srinivasan V; Agus MS
    Pediatr Diabetes; 2014 Mar; 15(2):75-83. PubMed ID: 24783254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose management in critically ill medical and surgical patients.
    Schiffner L
    Dimens Crit Care Nurs; 2014; 33(2):70-7. PubMed ID: 24496255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.
    Van den Berghe G; Wilmer A; Milants I; Wouters PJ; Bouckaert B; Bruyninckx F; Bouillon R; Schetz M
    Diabetes; 2006 Nov; 55(11):3151-9. PubMed ID: 17065355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose metabolism and insulin therapy.
    Langouche L; Van den Berghe G
    Crit Care Clin; 2006 Jan; 22(1):119-29, vii. PubMed ID: 16399023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
    Klonoff DC
    J Diabetes Sci Technol; 2011 May; 5(3):755-67. PubMed ID: 21722591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive insulin therapy versus conventional insulin therapy for critically ill trauma patients admitted to ICU.
    Aldawood AS; Tamim HM; Alsultan MA; Rishu AH; Arabi YM
    Middle East J Anaesthesiol; 2010 Jun; 20(5):659-66. PubMed ID: 20803853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.